Technical Analysis for MDP - Medexus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
C 1.770 1.14% 0.020
MDP closed up 1.14 percent on Thursday, May 2, 2024, on 31 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Walk Strength 1.14%
Outside Day Range Expansion 1.14%
Upper Bollinger Band Touch Strength 1.14%
Down 3 Days in a Row Weakness 1.14%
Gapped Down Weakness 1.14%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Medexus Pharmaceuticals Inc. Description

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.


Classification

Keywords: Health Infrastructure Healthcare Pharma Pipe Pharmaceutical Integrated Pipeline Disease Drugs Pharmaceuticals Diseases Arthritis Medication Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China Rheumatoid Arthritis

Is MDP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.53
52 Week Low 1.12
Average Volume 43,672
200-Day Moving Average 2.202
50-Day Moving Average 1.658
20-Day Moving Average 1.665
10-Day Moving Average 1.767
Average True Range 0.116
RSI (14) 55.16
ADX 20.75
+DI 23.815
-DI 18.099
Chandelier Exit (Long, 3 ATRs) 1.652
Chandelier Exit (Short, 3 ATRs) 1.818
Upper Bollinger Bands 1.917
Lower Bollinger Band 1.412
Percent B (%b) 0.71
BandWidth 30.303
MACD Line 0.045
MACD Signal Line 0.021
MACD Histogram 0.0233
Fundamentals Value
Market Cap 25.58 Million
Num Shares 14.5 Million
EPS -0.66
Price-to-Earnings (P/E) Ratio -2.69
Price-to-Sales 0.84
Price-to-Book 3.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.890
Resistance 3 (R3) 1.897 1.863 1.870
Resistance 2 (R2) 1.863 1.833 1.860 1.863
Resistance 1 (R1) 1.817 1.814 1.840 1.810 1.857
Pivot Point 1.783 1.783 1.795 1.780 1.783
Support 1 (S1) 1.737 1.753 1.760 1.730 1.683
Support 2 (S2) 1.703 1.734 1.700 1.677
Support 3 (S3) 1.657 1.703 1.670
Support 4 (S4) 1.650